$905M
$6.53 Million
0.0% of portfolio
411,901
Q4 2023
Added 15.69%
Neumora Therapeutics Inc.
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 86.46%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 16.91%
$233M
$17,000
0.0% of portfolio
1,440
Q2 2024
Added 4.72%
$207M
$17,000
0.0% of portfolio
3,067
Q4 2023
Added 1,104.24%
$847M
$936,000
0.0% of portfolio
112,755
Q4 2023
Reduced 47.02%
$3.06B
$6.29 Million
0.0% of portfolio
1,695,387
Q4 2023
Reduced 68.88%
$4.5B
$10.8 Million
0.0% of portfolio
219,494
Q4 2023
Added 2.82%
$1.07B
$7.92 Million
0.0% of portfolio
717,608
Q4 2023
Added 9.67%
$8.09B
$6 Million
0.0% of portfolio
125,571
Q4 2023
Added 1.03%
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 1.85%
$8.84B
$15.9 Million
0.0% of portfolio
321,489
Q4 2023
Added 12.15%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 52.2%
$2.53B
$8.09 Million
0.0% of portfolio
1,305,110
Q4 2023
Added 14.09%
$2.07B
$1.86 Million
0.0% of portfolio
152,595
Q4 2023
Reduced 4.73%
$7.17B
$7.13 Million
0.0% of portfolio
12,589
Q4 2023
Reduced 15.59%
$6.59B
$10.3 Million
0.0% of portfolio
339,556
Q4 2023
Added 18.79%
$280M
$23,000
0.0% of portfolio
1,999
Q4 2023
Added 1.37%
$656M
$5,000
0.0% of portfolio
933
Q3 2022
Reduced 69.11%
$3.28B
$2.8 Million
0.0% of portfolio
623,485
Q4 2023
Reduced 38.09%
$0
$11,000
0.0% of portfolio
2,876
Q4 2023
Reduced 8.14%
$210M
$8,000
0.0% of portfolio
573
Q4 2023
Reduced 29.78%
$887M
$5.84 Million
0.0% of portfolio
147,733
Q4 2023
Added 34.46%
$7.15B
$8.94 Million
0.0% of portfolio
49,890
Q4 2023
Added 4.59%
$1.65B
$1.17 Million
0.0% of portfolio
149,967
Q4 2023
Reduced 48.29%
$289M
$278,000
0.0% of portfolio
182,317
Q4 2023
Reduced 54.18%
$1.51B
$680,000
0.0% of portfolio
55,919
Q4 2023
Reduced 54.29%
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 87.68%
-
$0
0.0% of portfolio
-
Q2 2021
Reduced 15.87%
$420M
$36,000
0.0% of portfolio
5,227
Q2 2024
Added 3.81%
$2.01B
$1.5 Million
0.0% of portfolio
13,794
Q4 2023
Reduced 8.08%
$93.4M
$8,000
0.0% of portfolio
4,567
Q4 2023
Reduced 48.41%
$314M
$5,000
0.0% of portfolio
723
Q2 2021
Added 89.27%
$881M
$395,000
0.0% of portfolio
50,946
Q4 2023
Reduced 22.49%
$3.27B
$8.02 Million
0.0% of portfolio
222,587
Q4 2023
Added 3.28%
$88.2M
$8,000
0.0% of portfolio
3,979
Q2 2024
New
$743M
$42,000
0.0% of portfolio
4,503
Q2 2022
Reduced 96.94%
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 36.96%
$3.09B
$533,000
0.0% of portfolio
27,163
Q4 2023
Added 79.65%
$831M
$155,000
0.0% of portfolio
39,060
Q4 2023
Reduced 37.84%
$3.92B
$4.25 Million
0.0% of portfolio
173,892
Q4 2023
Reduced 10.66%
$406M
$361,000
0.0% of portfolio
22,919
Q4 2023
Reduced 19.84%
$719M
$610,000
0.0% of portfolio
6,672
Q4 2023
Reduced 91.91%
$384M
$25,000
0.0% of portfolio
1,102
Q4 2023
Reduced 9.6%
$2.14B
$7.48 Million
0.0% of portfolio
247,418
Q4 2023
Added 2.08%
$72.8M
$9,000
0.0% of portfolio
866
Q2 2024
New
$551M
$427,000
0.0% of portfolio
39,180
Q4 2023
Added 183.52%
$547M
$34,000
0.0% of portfolio
466
Q4 2023
Reduced 7.17%
$1.68B
$4.09 Million
0.0% of portfolio
340,145
Q4 2023
Added 0.06%
$1.47B
$11.1 Million
0.0% of portfolio
260,284
Q4 2023
Added 2.94%